EQUITY AWARDS (Tables)

3 Months Ended

Mar. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the three months ended March 31, 2020 and 2019 follows:

Three Months Ended March 31, 2020	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		508,000		$	26.68		6.24	$	3,159
Granted		23,000			29.00		9.84		11
Exercised		(3,000	)		24.00		2.54		—
Forfeited		(24,400	)		31.72		8.46		—
Balance, March 31, 2020		503,600		$	26.55		6.07	$	21
Exercisable at end of period		260,880		$	25.26		5.01	$	7

Three Months Ended March 31, 2019	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		537,872		$	26.49		6.96	$	2,088
Granted		19,000			29.80		9.90		—
Exercised		(19,172	)		25.08		6.14		79
Forfeited		(16,400	)		28.90		8.49		27
Balance, March 31, 2019		521,300		$	26.59		6.79	$	1,745
Exercisable at end of period		194,140		$	24.52		5.41	$	938

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the three months ended March 31, 2020 and 2019 follows:

Three Months Ended March 31, 2020	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		251,120		$	28.18		7.31	$	1,188
Granted		23,000			29.00		9.84		11
Vested		(8,200	)		27.45		7.19		—
Forfeited		(23,200	)		33.36		8.90		—
Balance, March 31, 2020		242,720		$	27.94		7.19	$	13

Three Months Ended March 31, 2019	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		331,560		$	27.74		7.77	$	975
Granted		19,000			29.80		9.90		—
Vested		(7,000	)		27.13		7.81		22
Forfeited		(16,400	)		28.90		8.49		27
Balance, March 31, 2019		327,160		$	27.81		7.61	$	807

Plan Information

Information related to stock options in the Plan is as follows for the three months ended:

	March 31, 2020		March 31, 2019
Intrinsic value of options exercised	$	—	$	79
Cash received from options exercised		72		481
Weighted average fair value of options granted		5.62		5.21

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the three months ended March 31, 2020 and 2019 follows:

Three Months Ended March 31, 2020	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		31,459		$	30.29
Granted		—			—
Vested		(6,100	)		30.25
Forfeited		—			—
Balance, March 31, 2020		25,359		$	30.29

Three Months Ended March 31, 2019	Number of Shares		Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		1,439	$	31.57
Granted		30,500		30.25
Vested		—		—
Forfeited		—		—
Balance, March 31, 2019		31,939	$	30.31